Introduction
Medium-chain ac}l CoA dehydrogenase (M(ADt {also called general acyI-CoA deh,vdrogenasel (E(" 1.3.99.3 ) is one of the mitochondrial acd (oA dehydrogenases catalyzing the first step of the fl-oxidalion c',de in the catabolism of fatLv acids. The enzyme is a tetramer of four identical ~ 44 kDa t, ubunils, containing one molecule of non-covaientl} bound FAD per subunil and catalyzes the dehydrogenation of Ca-('~: ac}l (hAs ~'ith maximal activity tov, ard the ('~ one. In thi., enzymatic reaction, electron transfer fla~.uprole n i,> the ~bligator,', natural electron acceptor ,.~hich reoqdize, the reduced enz3me [1] . MCAD ha, been purified t(, homogeneity from pig kidney [21. pig li~er [31. bovine liver [4] and rat It; or [5] . Like other nucleus-encysted &bhr,aiatwn. M('M) mcdlum-cMm a~ ',l (o.~ deh~dr,gcna-< d ( 1.3.99.3) : IPTG. l,.,)pr .tde: pRM ( (,,m>pondent:e K Y:lgL In.Hule uf Apphcd Bl,~h:rm-m,. 5.~gt Mcn3un,al Park. %tAe f;du q]54}1 JaFm mitochondrial proteins, the enz,.me i,~ s~nthe,,ized a~ a precur~,or ha~ing a leader peptide [6 ~l. The cDNAs encoding the enz',me v, ere imlated iram eDNA libraries of rat Iiwr [9.101 and partial eDNA, from human li,,er [11.12] and placenta [12] . Reeenlh, ae isolated a cl)NA for ,ML'a~D of nearh full length from human pJacema eDNA libra¢. 113] . Ih¢ molecular weights of the precursor and of the malure enzyme of rat liver were e~limated to be 466(10 and 43 7(1~) dalton,, respectively.: thus allo~,~ing for a leader peptide d 25 amino acid re, idues equaling 2900 dahons [9] . ]he precursor is Iran~,ferred through an energ,~-dependent n3L~'hanism into mit~hondria ~ her~.' it,, leader peplide i, dealed b~. protca,e-pn~e,,,ing t,, prodticc enz~rnatic.dh acme protein [8] . The leader peptide r, presumabl,, indispensable not onh for mlporhng and proces,,mg ,,te D in'.oMng mih~'hondriaI membrane pa,,sage, but ab.o for atlainment or the three-dimensional structure of lhe catal,.licalh, inactlw precursor From X-ra,~ diffraction stud; d pig liwr M(M) [14] . the flaun ring of the coenz., me seem, t, lie near tile Nit--terminal domain of the apoprotein. Therefore. deletion or modification of the NH.qerminal portion b, expected to give some informal|on on the pn~e,,s of the coenzsme binding for the enzxme aJcti~ir,. 1.3.99.3 ) is onc of the mitochondrial acyl (oA dehydro.. genases catalyzing the firs! step of the {J-oxidatiofl cycle in the catabolism of fally acids. The enzyme is a tetramer of four identical -44 kDa suhunit" containing one molecule of non ..wvaientlv hound FAD per suhunl\ and catalyzes the dehydrogenation of C . .C ,: acyl CoAs with maximal activity toward the C, onc. In thi, en .. zvmatic reaction. electron tran,fer Oa\oprotp n " the obligatory natural electron acceptor "hich reoxidize' the reduced enzyme [1] . publ. in: Biochimica et Biophysica Acta / Protein Structure and Molecular Enzymology, 1077 (1991), 3, pp. 285-290 Konstanzer 
('omtrucrion of expression pktsmid for rat liver MCA D
A nearly full-length eDNA for rat liver MCAD contained 1230 nucleotides of the coding region and 574 nucleotides of the 3'-noncoding region [10] . The eDNA ~e isolated coincided with that of Matsubara et al. [tl] except for the lacking of the first 30 nucleotides of the precursor. The eDNA was inserted into the EcoRl site of plasmid pUC 19. Expression plasmids for MCAD were constructed m two different ~ays: (1) the recombinant plasmid ',,,'as cleaved v, ith Hind I11 and ,St// 1. repaired with Klemwv fragment and ligated: (2) the recombinant plasmid was cleaved with Barn HI and Sph 1, treated with exonuclease Ill at 37°C to delete the 5"-region of the eDNA and aliquots were put into the buff or t40 mM sodium acetate (pH 4.5 Dassel. F.R.G.) and then incubated at 37°C for 6 h, The membranes were treated with chloroform vapor for 15 rain and then incubated overnight at room temperature with 5(1 mM Tris-HCI (pH 7.5) containing 0.15 M KCI. 20~ fetal calf serum. I mM DNase, 2 mg/ml of l.,,sozyme and 10 mM MgCI:. The membranes were immunostained by treating with the anIi-MCAD antiserum fotlowed by horseradish peroxidase-conjugated goat anti-rabbit igG as described previously [71.
Growth of bacteria and pr~Tamtion of cell~free evtract E. coil JMI09 cells carrying expression plasmids were grown aerobically at 37°C overnight in 2 ml of I_B medium containing 200 #g/ml of ampicillin and 2.5 mM IP'FG. The cells were harvested by centrifugation at 8000 x g for 10 rain. washed once with 50 mM Tris-ttCI (pll 7.4) containing 0.15 M KCI and resuspended m 500 ~tl of 10 mM Tris-HCI (pH 7.4) containing 1 mM EI)TA. The suspension was ruptured by multiple sonication (1(~1 watts, 30 s, 6 times), and cell debris we: ~ removed by centrifugation at 10000 × g for 15 rain. The supernatant was used as the cell-free extract.
Purificamm of rat liver M('A D produced in E, colt carrviJ~,g the eapre.~ion plasmid
]he cell-free extract (25 nil) prepared as described above from the culture (I I) was fractionated with ammopium sulfate (20 60% saturation). The fraction was dialyzed against buffer A (10 mM potassium phosphate (pH 7.4) containing 10% glycerol) and applied to a BioGel HTP column (25 × 10 cm) previously equilibrated with buffer A. The colmnn was washed with buffer A and eluted with a linear gradient of potassium phosphate (10 400 raM, pH 7.4) containing 10% glycerol. The fraction comaining MCAD. which was detected by inmmnoblotting using anti-pig kidney MCAD antiserum, was added with ammonium sulfate to 80~ saturation and the precipitate formed was diss~lved in 1 :,-! of buffer A containing 0.15 M KCI. The sample was subjected to get filtration on a BioGel A-5m column (1.0 x 90 cm) previously equilibrated with buffer A containing 0.15 M KCI. The fraction containing M('AD was pooled and stored in an ice bath until used.
Ass m' o] MCA D a~'tivily
MCAD activity was determined at 32°C by the phenazine methosulfate (I.5 mM)/dichlorophenolindophenol (DCIPI (0.(148 raM) method [2] using n-octanoyl CoA as substrate. One unit of the enzymatic activity was expressed by the amount of the enzyme that reduced I ttmo] of DCIP per rain.
Seqm,ncing of DNA and protein
The DNA sequence of plasmids was determined by the dideoxynucleotide chain termination method 116]
'.r~gl,'n "r lh~'\ICAD-~n~"ding~DNA pre\'iou,l\ isobled 1101. lh~enl\maticall\ acti\'e MCAD and the pmtein, having a part of the leader peptide or lackmg the' N H2-terl11inal region of the malo're form \\we ,,·nthe,il.~u in Escherichia ,oil. We descrihe hen: the pr"perti~s "I' these MCAD pmleins in reiatinl1 to the funuion of this el1Zvl11e.
Materials and Methods

.HaTerials
Enzymes for DNA manipulatinn. plasmid pUC 19 anu M lJ DNA sequen~ing kit were purchased from Takara Shuzo (Kyoto. Japan); F coli Hvll09. fmm ToY"Bo (Tob'". Japan); BioGe! HTI'. BioGc! A-5m and horsaadish peroxidase-conjugated goat anl!-rahhit Ig(;. from Rio-Rad Lahoratorks (Richmond. CA. Sl'h I. treated with exonuclease III at 37"C to delete thẽ '-region of the cDNA and alilluots were put into thh uff"r 140 mM sodium acetate (pH 4.5 
Purifim/iOlI of rat h,'('/' MeA D prod/Ked in E. coli mrr\,-lug rhe eXl'reHioll pla-'lIIid
The cell-free extract (25 ml) prepared as desnibed ahove fn.m the ,ulture (I I) was fractionated with ammonium sulfate (20-607. saturation). The fraction was dialYl.ed against huffer A (10 mM potassium phosphate (pH 7.4) containing IOW glycerol) and applied to a BioGeI HTI' column (25 x 10 cm) previously equilibrated with huffer A. The column was washed with hufl'er A and eluted with a linear gradient of potassium phosphate (10-400 mM. pH 7.4) containing 10% glycerol. The fraction containing MCAD. which was dete,ted hy immunohlotting using anti-pig kidney MCAD antiserum. was added with ammonium sulfate to KO e ;, saturation and thc precipitate formed was diss"lvl'(1 in I :"\ of huffer A containing 0.15 M KCI. The sample was ,;uhjected to gel filtration on a BioGeI A-5m column (1.0 x 90 cm) previously equilihrated with huffer A containing 0.15 M KCI. The fraction eontaining MCAD was pooled and stnrl'd in an ice hath until used.
A"a." of MCAD m-ril'ity
M('AD activity was determined at 32°C hy the phenazine methosulfate (1.5 mM)/dichloTOphenolindophenol (DClPl (0.041' mM) method [2J using Il-octanoyl ('oA as suhstrate. One unit of the enl.ymatic activity was expressed hy the amount of the enzyme that redu,ed 1 pmol of DClP per min.
Seql/cnclIlg of DNA and prolein
The DNA sequence of plasmids was determined by the dideoxynucleotide chain termination method [16] using an MI3 sequencing kit. The Nlt~-terminal amino acid sequence of the purified MCAI) was determined in a gas-phase sequenator (Model 470A, Applied Biosystems, Foster City, CA. U.S. A.) . High-performance liquid chromatography was carried out with a Shimadzu model LC-4A apparatus to quantitate the phertyhhiohydanloin derivatives produced at each cycle of Edman degradation [171.
Other analyses
Immunoblot analysis was carried out using anti-pig kidney MCAD antibody as described by Towbin et al.
[181. Protein content was dcternfined by the method of Lowry et al. [tg I using crystalline bovine serum albumin as standard.
Results
Expre.~Yirm nf eDNA cm'odmg rat lieer %4CA D m E, coil
In order to obtain clones produc :~g MCAD prorein, E. coh JMI09 cultures were t anslormed with 287 pRM(,'ADm series and colony immunoassay was carried out using anti-MCAD antiserum. Nine clones judged positive h', immunoassav ~erc isolated. Fig. I shows immunohlc, t an~tlvsis of MCAD proteins produced in E. coil carrying pRMCADm-1 -9, indicating the production of the anti-MCAD antibody-reactive proteins with various molecular masses (from 31 to 45 kDa). The extract from pRMCADm-l-bearing bacteria contained two smaller products (35 and 39 kl)a) that reacted with the antiserum, in addition to a 45-kDa protein. More than 90% of the protein produced by each clone was recovered in |he 10000 × g soluble fraction. These proteins were. hewever, not produced when the clones were grown in the absence of IPTG. The molectflar weights of the proteins were relati~,e to the expected length of the eDNA.
Restriction maps of the cDNAs confirmed the sequences of different length in the 5'-region, corresponding to the various molecular weigl, s. Fig. 2 shows the nucleotide sequences of the 5'-region of the cDNAs, where the downward arrows indicate the junction site between pU(" 19 and the cDNAs of pRMCADm-I, 2, 3, 4, 5 and 6.
Octanoyl CoA-dchydrogeuating activities of cell-free extracts from these antibody-positive clones were determined. The extract of E. cob carrying pRMCADm-3 sho~ed the highest enzymatic activity, whereas those from extracts of E. cob carrying pRMCADm-4 and pRMCADm-2 were approx, g0 and 60%, respectively. "Fhe extract of ~: coil bearing pRMCADm-5 showed only m~'-ginal activity and the ~ctivity in extracts from other clones was below the detection level (data no| shown).
Pl,ificartmt of mt lirer MCA Ds produced m E. cMi
Among these proteins, tho~,e produced in E. ~oh carrying pRMCADm-1, I and 6 ~ere purified to compare the characteristics of active and inactive enzymes. E. coli In order to ohtain dones prodUl: ;1g MC AD protein, E. m/I JM 109 <:ultures were l anstorrned with 2R7 pRMCADm serie, and <:olonv immunoassay was carried out using anti-MCAD antlscrum. Nine dnnes judged po,itive hv immunoassav were isolated. Fig. 1 shows immunohlot analysis of MCAD pWleins PWduced in E coli carrying pRMCADm-1 -9. indicating the production of the anti-MCAD antihody-reactive proteins with various molecular masses (fwm 31 to 45 kDa). The extract from pRMCADm-I-bearing hacteria wntained two smaller products (35 and 39 kDa) that reacted with the antiserum. in addition to a 45-kDa protein. More than 90% of the protein produced by each done was recovered in the 10000 x I: soluhle fraction. These proteins wcre. howevcr. not produced whcn the dones were grown in the ahsence of IPTG. The molecular weights <If the protein, were relative to the expected length of the <:DNA.
Restriction maps of the <:DNAs confirmed the sequences of different length in the 5'-region. mrresponding to the various molecular weights. Fig. 2 shows the nucleotide sequences of the 5'-region of the cDNAs. where the downward arrows indicate the junction site hetween pUC 19 and the cDNAs of pRMCADm-1. 2.
4. 5 and 6.
Octanoyl CoA-dchydrogenating activities of cell-free extracts from these antibody-positive clones were determined. The extract of E. coli carrying pRMC ADm-3 showed the highest enl.ymatic activity. whereas those from extracts of E. coli carrying pRMCADm-4 and pRMCADm-2 were approx. 90 and 60%. respectively. The extract of E. coli hearing pRMCADm-5 showed only m:"giml activity and the a<:tivity in extract, from other clones was helnw the detection level (data n<'t shown).
PlIriji'tullOlI of nil lil'fr MC AD.v produced ill E. coli
Among these proteins. those Vfoduccd in E coli carrying pRMCADm-1.1 and 6 were purified to compare the <:haracteristics of a<:tive and inactive enzymes. A typical result of the purification procedure for the protein directed by pRMCAD-3 is summarized in Table  I . From 485.6 mg protein of the cell-free extract, 3.94 mg of pure MCAD was obtained. Fig. 3 shows the result of sodium dodecyl sulfatc polyacrylamide gel electrophoresis (SDS-PAGE) and immunoblot analysis of samples obtained during purification. After hydroxyapatite column chromatography, the protein was almost homogenous; and minor contaminating proteins were removed by gel filtration.
The MCAD proteins of ~ 40 and -45 kDa were purified by the same procedure from 216 and 306 mg total protein from E. colt harboring pRMCADm-6 and -1, respectively. Their yields were 1.2 mg and 0.24 rag, respectively.
NH:-termi,al sequence o/the purified MCA D produced m E. ¢oli carrring pRMCA Din-3
Fig . 4 compares the amino acid sequence (B) of the NH ~-terminal region of MCAD deduced from the DNA sequence (A) with that determined by amino acid sequencing of the purified MCAD (C}, indicating correctness of the assumed NH:-terminal sequence.
Properties o/the purified MCA Ds produced in £ colt
The absorption spectrum of the purified MCAD from pRMCADm-3-infected cells exhibited maxima at 275, 370. and 445 nm at pH 7.4 (Table !i). Fig. 5 shows the visible absorption spectrum, which coincides with that of MCAD purified from rat liver mitochondria. The properties of the enzyme purified from pRMCADm-3-infected cells fairly agree with those of MCAD from rat liver mitochondria (]'able II). FAD was released by treating the purified MCAD with 5% trichloroacetic acid. indicating that it is non-covalently cl Fwm RcI'. 9, MeJsured at pI! 7.4 275. 370. and 445 nm at pH 7.4 (Table 11 ) . Fig. 5 shows the visible absorption spectrum. which coincides with that of MeAD purified from rat liver mitochondria. The properties of the enzyme purified from pRMCADm-3-infected cells fairly agree with those of MCAD from rat liver mitochondria (Table 11) . FAD was released by treating the purified MCAD with 5% trichloroacetic acid. indicating that it is non-covalently 21.5-
31.0-
NH:-Iermilw! sequence of Ihe purified MC4 D produced ill E. <oli mrrl'il1g pRMCADm-3
Fig . 4 compares the amino acid sequence (B) of the NH,-terminal region of MCAD deduced from the DNA sequence (A) with that determined by amino acid sequcncing of the purified MCAD (C). indicating correctness of the assumed NH,-terminal sequence.
Properties of /he purified MCADs produced ill E. coli
The absorption spectrum of the purified MCAD from pRMCADm-3-infected cells exhibited mJxima at 1 2 A typical result of the purification pmcedure for the protein directed by pRMCAD-3 is summari7.ed in Table   I . From 4l;S.6 mg protein of the cell-free extract. 3.94 mg of pure MCAD was obtained. Fig. 3 shows the resuh of sodium dodecyl sulfate polyacrylamide gel electropr.oresis (SOS-PAGE) and immunoblot analysis of samples obtained during purification. After hydroxyapatite column chromatography. the protein was almost homogenous; and minor contaminating proteins were removed by gel filtration.
The MCAD proteins of -40 and -45 kDa were purified by the same procedure from 216 and 306 mg total protein from E. coli harboring pRMCADm-6 and -J. respcctively. Their yields were 1.2 mg and 0.24 mg.
respectively. Wavelength (nm) Fig. 5 . Visible absorption spectra of purified MCADs produced in E. cob carrying pRM('ADm-1, -3 and -6. The purified MCAD (0.15 mg/mll '~,as dialyzed against 511 mM potassium phosphate buffer (pH 7.4) and its spectrum was measured I, MCAD pr~nluced with pRMCADm-I: II. that with pRMCADm-3; I11. that with pRMCADm-6.
bound. On the other hand, the purified proteins directed by pRMCADm-I and pRMCADm-6 did not contain FAD as can be seen in Fig. 5 and showed no enzymatic activity. Also, no activity was observed upon addition of FAD.
Discussion
Precursor proteins including a leader peptide have been reported to form an insoluble material termed "inclusion body" [20] when synthesized in E. colt. On the other hand, precursors without a leader peptide, such as those of cytosolic proteins, are expressed in a soluble form in the bacteria [21, 22] . In the present study, the rat liver MCAD proteins synthesized in E. coil were recovered in the 10000 × g soluble fraction. This is interpreted as indicating the deletion of amino acids (more than 10 residues) from the leader peptide. This also agrees with the results of Jaussi et al. [23] , who reported that the insoluble precursor of chicken mitochondrial aspartate aminotransferase synthesized in E. coil was cenverted to a soluble enzyme upon removal of the leader peptide.
The protein synthesized in pRMCADm-3-infected E. eoli was expected to be a hybrid protein, since the plasmid contained information for eight extra amino acids of the NH~-terminal region as shown in Fig. 4 . However, in the NH,-terminal sequence obtained from the purified protein, this extra peptide was found to be absent. This is assumed to be due to the action of bacterial proteinases.
The protein from pRMCADm-3 was purified to homogeneity by a simple procedure using solely hydroxyapatite column chromatography and gel filtration. This protein contained non-covalently bound FAD, and its absoption spectrum in the visible region fairly agreed with those of MCAD from rat liver mitocbondria [2] [3] [4] [5] . This indicates that FAD in the bacteria is readily available and binds to the apoprotein either during or after the folding of the polypeptide chain, resulting in a stable form. The binding of prosthetic group to apoprotein synthesized in E. coil was also reported in the cases of rat liver NADPH-cytochrome P-450 oxidoreductase [24] and of rat liver aspartate aminotransferase I221.
The enzymatic properties of the purified MCAD from pRMCADm-3-bearing bacteria were fairly similar to those of the enzyme from rat liver mitoehondria. It should be pointed out that activity determinations with MCAD are subject of considerable variation due to difficulties inherent to the assay systems, as noted by several authors 12,25]. The differences to be seen in Table II . in particular that in K m, might not be significant. However, this problem should await further investigation.
The MCAD purified from the cells carrying pRMCADm-! did not contain FAD and showed no activity, even in the presence of added FAD. Since the protein directed by pRMCADm-1 has a substantial portion of the ~eader peptide, the binding of the flavin coenzyme to the apoprotein is probably prevented by the leader peptide.
Further, the MCAD protein purified from pRMCADm-6-bearing cells did not contain any FAD and showed no enzymatic activity, even in the presence of FAD. The c~stallographic structure of MCAD from pig liver mitochondria made by Kim and Wu [141 showed that this enzyme consist~ of three domains. The NHz-terminal domain is composed of 6 a-helices, the middle one is packed with B-sheets, and the C-terminal one is composed again of 6 a-helices, av, d the flavin ring lies in the crevice between the first two domains. From the three-dimensional structure, it is apparent that the NH2-terminal portion of the polypeplide participates in the flavin binding. The deletion of 42 amino acid residues in the protein direc:_d by pRMCADm-6 implies the absence of the Grst hehx of the NHz-terminal portion I14]. Apparently, the absence of this region results in the failure in forming the functional three-dimensional structure of the mature enzyme, which makes the apoenzyme unable to combine with FAD. bound. On the other hand. the purified proteins directed by pRMCADm-1 and pRMCADm-6 did not contain FAD as can be seen in Fig. 5 and showed no enzymatlc activity. Also, no activity was observed upon addition of FAD.
Precursor proteins induding a leader peptide have been reported to form an insoluble material termed 'inclusion body' [20) when synthesized in E. ("oli. On the other hand. precursors wilhout a leader peptid. : . such as those of cytosolic proteins. are expressed in a soluble form in the bacteria [21, 22) . In the present study. the rat liver MC AD proteins synthesized in F.. coli were recovered in the 10000 X g soluble fraction. This is interpreted as indicating the deletion of amino acids (more than 10 residues) from the leader peptide. This also agrees with the results of Jaussi et al. [23] , who reported that the insoluble precursor of~hicken mitochondrial aspartate aminotransferase synthesized in E. coli was ccnverted to a soluhle enzyme upon removal of the leader peptide.
The protein synthesized in pRMC ADm-3-infecteJ E.
coli was expected to be a hybrid protein, since the plasmid contained information for eight extra amino acids of the NH 2 -terminal region as shown in Fig. 4 . However, in the NH 2 -terminal sequence ohtained from the purified protein, this extra peptide was found to be absent. This is assumed to be due to the action of bacterial proteinases.
The protein from pRMCADm-3 was purified to homogeneity by a simple procedure using solely hydroxyapatite column chromatography and gel Wtration. This protein contained non-covalently bound FAD. and its abso'ption spectrum in the visible region fairly agreed 289 with those of MCAD from rat liver mitochondria [2-51. This indi~ates that FAD in the hacteria i, readily availahle and binds to the apoprotein either during or after the folding of the polypeptide chain. resulting in a stable form. The binding of prosthetic group to apoprotein synthesized in E. coli was also reported in the cases of rat liver NADPH-cytochrome P-450 oxidoreductase [24] and of rat liver aspartate aminotransferase [22] .
The enzymatic properties of the purified MCAD from pRMCADm-3-bearing bacteria were fairly similar to those of the enzyme from rat liver mitochondria. It should be pointed out that activity determinations with MCAD are subject of considerable varialion due to difficulties inherent to the assay systems. as noted by several authors [2.25] . The differences to be seen in Table 11 . in particular that in Km' might not be significant. However. this problem should await further investigation.
The MCAD purified from the cells carryir.g pRMCADm-l did not contain FAD and showed no activity. even in the presence of added FAD. Since the protein directed by pRMCADm-l has a substantial portion of the !eader peptide, the binding of the flavin coenzyme to the apoprotein is probably prevented by the leader peptide.
Further. the MCAD protein purified from pRMCADm-6-bearing cells did not contain any FAD and showed no enzymatic activity. even in the presence of FAD. The crystallographic structure of MCAD from pig liver mitochondria made by Kim and Wu [14] showed that this enzyme wnsists of three domains. The NH:-lerminal domain is composed of 6 a-helices. the middle one is packed with ,B-sheets. and the C-terminal one is composed again of 6 a-helices, ar.d the flavin ring lies in the crevice between the first two domains. From the three-dimensional structure. it is apparent that the NH:-terminal portion of the polypeptide parl1C1pates in the flavin binding. The deletion of 42 ammo acid resldues in the protein direC:.d by pRMCADm-6 implies the absence of the f;rst hehx of the NH:-terminal portion [14] . Apparenlly. the ahsence of this region results in the failure in forming the functional three-dimensional structure of the mature enzyme. which makes the apoenzyme unable to combine with FAD.
